Yasunao Kogashiwa

Yasunao Kogashiwa

Auto-generated profile, based on publicly available information

Yasunao Kogashiwa

Department of Head and Neck Surgery, Otolaryngology Saitama Medical University International Medical Center Hidaka Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2017 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
YKYasunao Kogashiwa
Yasunao Kogashiwa
MYMasanori Yasuda
Masanori Yasuda
HSHiroyuki Sakurai
Hiroyuki Sakurai
MNMitsuhiko Nakahira
Mitsuhiko Nakahira
YSYoshie Sano
Yoshie Sano
MSMasashi Sugasawa
Masashi Sugasawa
Background/Aim: Clinical trials with therapies targeting immune checkpoint molecules have shown promising results in several tumor types. However, the predictive and prognostic values of these immunological factors for locally advanced oral squamous cell carcinomas (LAOSCC) remain unclear. Our purpose was to evaluate the expression and prognostic value of programmed cell death-ligand1 (PD-L1) and PD-L2 and to correlate their expression with the degree of infiltration by CD8+ cells in LAOSCC. Patients and Methods: A total of 84 patients with LAOSCC were included. PD-L1, PD-L2 and CD8 expression was detected in the tumor tissue using immunohistochemistry and was tested for correlation with clinical outcome. Results: PD-L1 and PD-L2 were expressed in 52.4% and 23.8% of LAOSCC cases, respectively. PD-L1 positivity was significantly associated with superior disease-free (p=0.024) and overall (p=0.008) survival of the patients and retained significance in multivariate analysis. PD-L1 positivity was correlated with CD8 density. Conclusion: PD-L1 expression was associated with CD8+ tumor-infiltrating lymphocytes and better outcome in patients with LAOSCC.

23 January 2018 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
YSYoshie Sano
Yoshie Sano
YKYasunao Kogashiwa
Yasunao Kogashiwa
RARyuichiro Araki
Ryuichiro Araki
YEYuichiro Enoki
Yuichiro Enoki
TITetsuya Ikeda
Tetsuya Ikeda
MSMasashi Sugasawa
Masashi Sugasawa

11 January 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
YEYasuhiro Ebihara
Yasuhiro Ebihara
SYSaori Yoshida
Saori Yoshida
MNMitsuhiko Nakahira
Mitsuhiko Nakahira
YKYasunao Kogashiwa
Yasunao Kogashiwa
YEYuichiro Enoki
Yuichiro Enoki
MSMasashi Sugasawa
Masashi Sugasawa

10 October 2018 in Head & Neck
Verified
Journal Article
Closed access
PDF file
YKYasunao Kogashiwa
Yasunao Kogashiwa
HIHitoshi Inoue
Hitoshi Inoue
KKKiyomi Kuba
Kiyomi Kuba
RARyuichiro Araki
Ryuichiro Araki
MYMasanori Yasuda
Masanori Yasuda
MSMasashi Sugasawa
Masashi Sugasawa

1 April 2021 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
HIHitoshi Inoue
Hitoshi Inoue
MHMasataka Hirasaki
Masataka Hirasaki
YKYasunao Kogashiwa
Yasunao Kogashiwa
KKKiyomi Kuba
Kiyomi Kuba
YEYasuhiro Ebihara
Yasuhiro Ebihara
MSMasashi Sugasawa
Masashi Sugasawa
Human papillomavirus (HPV)-negative oropharyngeal squamous cell carcinoma shows a higher rate of radiation resistance than HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). Radioresistant... 背景:人类乳头瘤病毒(HPV)阴性的口咽鳞状细胞癌显示出比HPV阳性口咽鳞状细胞癌(OPSCC)更高的抗放射率。抗放射性HPV阴性OPSCC与不良预后相关, 但仍缺乏经过验证的预后生物标志物。目的:本研究探讨了抗放射性HPV阴性OPSCC的生物标志物。材料和方法:《癌症基因组图集》囊括了来自528例HNSCC肿瘤的miRNA序列和mRNA序列数据。其中, 我们将基因表达数据用于HPV阴性头颈...

10 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YKYasunao Kogashiwa
Yasunao Kogashiwa
HSHiroyuki Sakurai
Hiroyuki Sakurai
YAYoshihiro Akimoto
Yoshihiro Akimoto
DSDai Sato
Dai Sato
TITetsuya Ikeda
Tetsuya Ikeda
NKNaoyuki Kohno
Naoyuki Kohno
Sentinel node navigation surgery is gaining popularity in oral cancer. We assessed application of sentinel lymph node navigation surgery to pharyngeal and laryngeal cancers by evaluating the combination of contrast-enhanced ultrasonography and indocyanine green fluorescence in animal models. This was a prospective, nonrandomized, experimental study in rabbit and swine animal models. A mixture of indocyanine green and Sonazoid was used as the tracer. The tracer mixture was injected into the tongue, larynx, or pharynx. The sentinel lymph nodes were identified transcutaneously by infra-red camera and contrast-enhanced ultrasonography. Detection time and extraction time of the sentinel lymph nodes were measured. The safety of the tracer mixture in terms of mucosal reaction was evaluated macroscopically and microscopically. Sentinel lymph nodes were detected transcutaneously by contrast-enhanced ultrasonography alone. The number of sentinel lymph nodes detected was one or two. Despite observation of contrast enhancement of Sonazoid for at least 90 minutes, the number of sentinel lymph nodes detected did not change. The average extraction time of sentinel lymph nodes was 4.8 minutes. Indocyanine green fluorescence offered visual information during lymph node biopsy. The safety of the tracer was confirmed by absence of laryngeal edema both macro and microscopically. The combination method of indocyanine green fluorescence and contrast-enhanced ultrasonography for detecting sentinel lymph nodes during surgery for head and neck cancer seems promising, especially for pharyngeal and laryngeal cancer. Further clinical studies to confirm this are warranted.